Ming-Kai Chen, MD, PhD
Associate Professor of Radiology and Biomedical Imaging; Co-Medical Director, Yale University PET Center
Research & Publications
Biography
News
Coauthors
Research Interests
Diagnosis; Neoplasms; Nervous System Diseases; Health Care
Public Health Interests
Environmental Health
Selected Publications
- Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.Chen MK, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin SF, Najafzadeh S, Ropchan J, Lu Y, McDonald JW, Michalak HR, Nabulsi NB, Arnsten AFT, Huang Y, Carson RE, van Dyck CH. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging. JAMA Neurology 2018, 75: 1215-1224. PMID: 30014145, PMCID: PMC6233853, DOI: 10.1001/jamaneurol.2018.1836.
- (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.Park E, Gallezot JD, Delgadillo A, Liu S, Planeta B, Lin SF, O'Connor KC, Lim K, Lee JY, Chastre A, Chen MK, Seneca N, Leppert D, Huang Y, Carson RE, Pelletier D. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas. European Journal Of Nuclear Medicine And Molecular Imaging 2015, 42: 1081-92. PMID: 25833352, DOI: 10.1007/s00259-015-3043-4.
- What is the role of dosimetry in patients with advanced thyroid cancer?Chen MK, Cheng DW. What is the role of dosimetry in patients with advanced thyroid cancer? Current Opinion In Oncology 2015, 27: 33-7. PMID: 25319079, DOI: 10.1097/CCO.0000000000000145.
- Determining the Minimal Required Radioactivity of 18F-FDG for Reliable Semiquantification in PET/CT Imaging: A Phantom Study.Chen MK, Menard DH, Cheng DW. Determining the Minimal Required Radioactivity of 18F-FDG for Reliable Semiquantification in PET/CT Imaging: A Phantom Study. Journal Of Nuclear Medicine Technology 2016, 44: 26-30. PMID: 26769598, DOI: 10.2967/jnmt.115.165258.
- Imaging synaptic density in the living human brain.Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin SF, Chen MK, Dhaher R, Matuskey D, Baum E, Holden D, Spencer DD, Mercier J, Hannestad J, Huang Y, Carson RE. Imaging synaptic density in the living human brain. Science Translational Medicine 2016, 8: 348ra96. PMID: 27440727, DOI: 10.1126/scitranslmed.aaf6667.
- Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.Finnema SJ, Nabulsi NB, Mercier J, Lin SF, Chen MK, Matuskey D, Gallezot JD, Henry S, Hannestad J, Huang Y, Carson RE. Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans. Journal Of Cerebral Blood Flow And Metabolism : Official Journal Of The International Society Of Cerebral Blood Flow And Metabolism 2018, 38: 2041-2052. PMID: 28792356, PMCID: PMC6259313, DOI: 10.1177/0271678X17724947.
- Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected dose.Ye Q, Wu J, Lu Y, Naganawa M, Gallezot JD, Ma T, Liu Y, Tanoue L, Detterbeck F, Blasberg J, Chen MK, Casey M, Carson RE, Liu C. Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected dose. Physics In Medicine And Biology 2018, 63: 175015. PMID: 30095083, PMCID: PMC6158045, DOI: 10.1088/1361-6560/aad97f.
- The utility of I-123 pretherapy scan in I-131 radioiodine therapy for thyroid cancer.Chen MK, Yasrebi M, Samii J, Staib LH, Doddamane I, Cheng DW. The utility of I-123 pretherapy scan in I-131 radioiodine therapy for thyroid cancer. Thyroid : Official Journal Of The American Thyroid Association 2012, 22: 304-9. PMID: 22300251, DOI: 10.1089/thy.2011.0203.
- Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management.Chen MK, Doddamane I, Cheng DW. Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management. Current Opinion In Oncology 2010, 22: 6-10. PMID: 19844179, DOI: 10.1097/CCO.0b013e3283339d5d.
- Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization.Chen MK, Baidoo K, Verina T, Guilarte TR. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain : A Journal Of Neurology 2004, 127: 1379-92. PMID: 15069023, DOI: 10.1093/brain/awh161.
- Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination.Chen MK, Guilarte TR. Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. Toxicological Sciences : An Official Journal Of The Society Of Toxicology 2006, 91: 532-9. PMID: 16554315, DOI: 10.1093/toxsci/kfj172.
- Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair.Chen MK, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacology & Therapeutics 2008, 118: 1-17. PMID: 18374421, PMCID: PMC2453598, DOI: 10.1016/j.pharmthera.2007.12.004.
- VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease.Chen MK, Kuwabara H, Zhou Y, Adams RJ, Brasić JR, McGlothan JL, Verina T, Burton NC, Alexander M, Kumar A, Wong DF, Guilarte TR. VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease. Journal Of Neurochemistry 2008, 105: 78-90. PMID: 17988241, PMCID: PMC4137401, DOI: 10.1111/j.1471-4159.2007.05108.x.